Removing small rectal tumors with a scope
Part of Cancer, Digestive system clinical trials.
This study is testing whether a minimally invasive endoscopic procedure (using a scope through the anus) can safely remove small rectal neuroendocrine tumors. If you're eligible, this could be a less invasive way to treat your condition without major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a small neuroendocrine tumor in your rectum (10 mm or smaller).
- The tumor has not spread to lymph nodes or other parts of the body.
- You have not had surgery for this tumor before.
- You are willing to have the tumor removed using a scope through the anus (either a modified EMR or ESD procedure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies two ways to remove small rectal neuroendocrine tumors (slow-growing tumors in the rectum) using an endoscope. It aims to see which method works better and if it can be done safely and effectively without more invasive surgery.
This study compares two minimally invasive ways to remove small rectal neuroendocrine tumors (NETs), which are growths in the rectum that are usually not cancer. The goal is to find which method is safer and more effective with fewer side effects.
This trial tests whether using a special traction device during endoscopic removal of small rectal neuroendocrine tumors is safer or more effective than the standard method. It may help patients with these tumors have a less invasive treatment.
This study compares two ways of removing very small rectal neuroendocrine tumors (less than 1 cm): a modified technique using a special snare (mDS-EMR) versus a more involved removal called ESD. Both are done through a scope (endoscopy) without major surgery.
This study compares two minimally invasive endoscopic techniques—ESD and EPMR—for removing small neuroendocrine tumors (slow-growing hormone-producing tumors) in the rectum. The goal is to see which approach works better and is safer for patients.
This trial tests a new robotic system to remove large, flat growths in the lower part of the rectum that are too big for standard removal. The goal is to remove the growth completely in one piece, which may help avoid more invasive surgery.
Hear when a new Rectal Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.